Mode
Text Size
Log in / Sign up

Non-invasive neural stimulation improves upper limb function in subacute stroke: meta-analysisBrain stimulation may help stroke survivors regain arm function

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider NINS as an adjunct for upper limb recovery in subacute stroke, but interpret results cautiously due to heterogeneity.

This systematic review and meta-analysis of 24 randomized controlled trials involving 1091 patients with subacute stroke (7 days to 6 months) evaluated the effects of non-invasive neural stimulation (NINS) modalities, including transcranial direct current stimulation (tDCS), on upper limb function and activities of daily living. The primary outcomes included the Fugl-Meyer Assessment for Upper Extremity (FMA-UE), Barthel Index, Action Research Arm Test (ARAT), Wolf Motor Function Test (WMFT), and Modified Ashworth Scale (MAS).

Pooled analyses showed statistically significant between-group differences favoring NINS over sham or standard care across multiple measures: FMA-UE (SMD = 0.60; 95% CI 0.30 to 0.89), Barthel Index (SMD = 0.77; 95% CI 0.42 to 1.13), ARAT (SMD = 0.66; 95% CI 0.40 to 0.93), and WMFT (SMD = 0.75; 95% CI 0.22 to 1.27). A subgroup analysis of tDCS also showed a statistically significant difference in MAS scores.

The authors note substantial heterogeneity and methodological variability across studies, which limits the interpretability of pooled estimates. Residual heterogeneity may reflect unmeasured confounders. No safety data were reported. The evidence is considered low certainty, and the findings should be interpreted cautiously. NINS may be associated with modest, context-dependent improvements, but further large-scale, high-quality trials are required.

If you or someone you love has had a stroke, you know how hard it can be to get an arm or hand to work again. A new analysis of 24 clinical trials, involving over 1,000 people, suggests that a gentle form of brain stimulation might help.

The technique, called non-invasive neural stimulation (NINS), uses devices like transcranial direct current stimulation (tDCS) to send a weak electrical current through the scalp. In the studies, people who received NINS showed modestly better arm function and ability to perform daily tasks compared to those who got sham treatment or standard care.

But here's the honest truth: the evidence is still shaky. The studies varied widely in how they were done, and the results were not consistent. The researchers caution that the findings should be interpreted carefully. No single type of stimulation stood out as clearly better than others.

For now, this is not a proven treatment. It's a promising clue that needs more research. If you're recovering from a stroke, talk to your doctor about what therapies are right for you.

What this means for you:
Non-invasive brain stimulation may modestly help arm recovery after stroke, but evidence is low certainty.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
IntroductionNon-invasive neural stimulation (NINS) has been increasingly adopted as an adjunctive strategy in stroke rehabilitation. However, its effectiveness in improving upper limb function during the subacute stage remains uncertain. This study aimed to evaluate the effects of different NINS modalities on upper limb function and activities of daily living in patients with subacute stroke.MethodsA systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted. PubMed, Embase, Web of Science, Cochrane Library, and major Chinese databases (CNKI, Wanfang, VIP) were systematically searched from inception to October 2025. Eligible studies included adult patients with subacute stroke (7 d–6 m) receiving NINS. The primary outcomes were upper limb function and activities of daily living. Outcome data were extracted at the end of the intervention for quantitative synthesis. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup and meta-regression analyses prespecified in the study protocol were conducted based on recovery stage and stimulation modalities.ResultsA total of 24 RCTs (n = 1,091 patients) were included. Compared with the control group, statistically substantial between-group differences were observed for FMA-UE [SMD = 0.60, 95% CI (0.30, 0.89)], Barthel Index [SMD = 0.77, 95% CI (0.42, 1.13)], ARAT [SMD = 0.66, 95% CI (0.40, 0.93)], and WMFT [SMD = 0.75, 95% CI (0.22, 1.27)] (all p  0.05). Subgroup analyses showed substantial between-group differences in some modality-specific comparisons; however, no clear superiority was observed. In the transcranial direct current stimulation (tDCS) subgroup, a statistically substantial between-group difference in MAS scores was observed. Residual heterogeneity may reflect unmeasured confounders and limit the interpretability of pooled estimates.ConclusionNINS may be associated with modest, context-dependent improvements in upper limb function and activities of daily living in patients with subacute stroke. However, given the substantial heterogeneity and methodological variability, current evidence remains limited and should be interpreted cautiously. Further large-scale, high-quality trials are required to clarify optimal stimulation modalities and clinical applicability.Systematic review registrationPROSPERO, CRD420251242784.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.